Electroacupuncture Combined With Paclitaxel Protein-bound and PD-1 Antibody for Second-line Treatment of HER2 Negative, pMMR/MSS Advanced Gastric Cancer
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Electroacupuncture Combined With Paclitaxel Protein-bound and PD-1 Antibody for Second-line Treatment of HER2 Negative, pMMR/MSS Advanced Gastric Cancer (NCT06992024) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2025-04-01 |
Track Electroacupuncture Combined With Paclitaxel Protein-bound and PD-1 Antibody for Second-line Treatment of HER2 Negative, pMMR/MSS Advanced Gastric Cancer automatically
Every clearance here is in the API, with alerts when new ones post.